Prof. in Clinical Pharmacy & Head of the Department of Clinical Pharmacy at the University of Innsbruck
After the webinar, participants should be able to:
- Describe the range of AI tools available for scientific writing and conducting a literature review.
- Make an informed decision about the advantages and limitations of using these in practice.
- Describe professional and ethical considerations associated with the use of artificial intelligence in the scientific writing process.
- Understand the guidance provided by large scientific publishing companies on the use of AI in the publication process.
The aim of this webinar is to provide an overview of AI tools available for scientific writing, literature review and publication from a practical lens enabling attendees to better understand the advantages and limitations of each tool.
Prof. Anita E. Weidmann, MRPharmS, MFRPSII, SFHEA, PhD is the Head of the Clinical Pharmacy Department at the University of Innsbruck, Austria. She is a visiting Prof. at the and the Karl-Franzens University in Graz, Austria and the Robert Gordon University, Aberdeen. She has previously held positions at the School of Pharmacy and Life Sciences in Aberdeen, Scotland; the Apoptosis Research Institute at the Children’s Hospital of Eastern Ontario, Canada and the Hospital Pharmacy Department of Addenbrookes Hospital in Cambridge, UK. She is an Associate Editor for the International Journal of Clinical Pharmacy and the European Journal of Hospital Pharmacy and on the Editorial Board Research and Social Administrative Pharmacy. She is a member of the Research Committee for the European Society of Clinical Pharmacy; a member of the Scientific Committee for the Austrian Patient Safety Platform and an advisor on several expert groups for the Austrian Ministry of Health.
Prof. Weidmann has a long list of peered reviewed publications which centre around her research focus, Medication Therapy- and Patient Safety. She is interested in patient-centred issues, evaluation-based research of existing clinical services; needs assessments for the development of clinical services to inform legislative changes and academic curricula; as well as implementation research for clinical pharmacy services. Her current research addresses the optimizing drug therapy safety of high-risk medications; developing a comprehensive medication risk tool for the avoidance of delirium in hospitalised patients or the development of clinical pharmacy services in hospital pharmacies. She has a wide international research network and as PI has most recently been awarded the paper of the year award 2022 by the International Journal of Clinical Pharmacy.